ATAI Life Sciences N.V. (NASDAQ: ATAI): Do Not Miss The Gain Train

ATAI Life Sciences N.V. (ATAI) concluded trading on Wednesday at a closing price of $2.39, with 9.93 million shares of worth about $23.73 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 92.74% during that period and on April 3, 2024 the price saw a gain of about 27.81%. Currently the company’s common shares owned by public are about 166.03M shares, out of which, 115.36M shares are available for trading.

Stock saw a price change of 38.15% in past 5 days and over the past one month there was a price change of 14.35%. Year-to-date (YTD), ATAI shares are showing a performance of 69.50% which increased to 32.04% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.02 but also hit the highest price of $2.39 during that period. The average intraday trading volume for ATAI Life Sciences N.V. shares is 1.52 million. The stock is currently trading 30.14% above its 20-day simple moving average (SMA20), while that difference is up 29.81% for SMA50 and it goes to 49.22% higher than SMA200.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

ATAI Life Sciences N.V. (NASDAQ: ATAI) currently have 166.03M outstanding shares and institutions hold larger chunk of about 8.22% of that.

The stock has a current market capitalization of $396.81M and its 3Y-monthly beta is at 0.97. It has posted earnings per share of -$0.26 in the same period. It has Quick Ratio of 9.22 while making debt-to-equity ratio of 0.07. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ATAI, volatility over the week remained 15.19% while standing at 10.19% over the month.

Analysts are in expectations that ATAI Life Sciences N.V. (ATAI) stock would likely to be making an EPS of -$0.17 in the current quarter, while forecast for next quarter EPS is -$0.19 and it is -$0.75 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.22 which is -$0.14 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.21 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -198.67% while it is estimated to increase by 0.63% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on Apr-04-24 offering a Buy rating for the stock and assigned a target price of $6 to it. Coverage by Loop Capital stated ATAI Life Sciences N.V. (ATAI) stock as a Buy in their note to investors on November 01, 2022, suggesting a price target of $18 for the stock. On November 30, 2021, Maxim Group Initiated their recommendations, while on November 11, 2021, ROTH Capital Initiated their ratings for the stock with a price target of $32. Stock get a Buy rating from H.C. Wainwright on October 18, 2021.

Most Popular

Related Posts